Skip to product information
1 of 1

Gene Bio Systems

LGALS3BP Antibody - Cat. #: CSB-PA594413

LGALS3BP Antibody - Cat. #: CSB-PA594413

SKU:CSB-PA594413

Regular price $416.00 USD
Regular price Sale price $416.00 USD
Sale Sold out
Shipping calculated at checkout.

Size :50ul

Clone Number:

Aliases:90K antibody; 90K MAC 2 BP antibody; Basement membrane autoantigen p105 antibody; BTBD17B antibody; Galectin 3 binding protein antibody; Galectin-3-binding protein antibody; L3 antigen antibody; Lectin galactoside binding soluble 3 binding protein antibody; Lectin galactoside-binding soluble 3-binding protein antibody; LG3BP_HUMAN antibody; LGALS3BP antibody; M2BP antibody; Mac 2 binding protein antibody; Mac 2 BP antibody; Mac-2 BP antibody; Mac-2-binding protein antibody; Mac2 BP antibody; MAC2BP antibody; Serum protein 90K antibody; TANGO10B antibody; Transport and golgi organization 10 homolog B antibody; Tumor associated antigen 90K antibody; Tumor-associated antigen 90K antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:Q08380

Immunogen:Fusion protein of Human LGALS3BP

Raised in:Rabbit

Species Reactivity:Human

Tested Applications:ELISA, IHC; ELISA:1:2000-1:5000, IHC:1:20-1:100

Background:The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS3BP has been found elevated in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV). It appears to be implicated in immune response associated with natural killer (NK) and lymphokine-activated killer (LAK) cell cytotoxicity. Using fluorescence in situ hybridization the full length 90K cDNA has been localized to chromosome 17q25.

Clonality:Polyclonal

Isotype:IgG

Purification Method:Antigen affinity purification

Conjugate:Non-conjugated

Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:LGALS3BP

Research Areas:Cancer

View full details